Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows its promise for gene editing (IMAGE)

St. Jude Children's Research Hospital

Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows its promise for gene editing

Caption

Elizabeth Kellogg, PhD, St. Jude Department of Structural Biology, used cryo-EM to study the evolutionary journey of Fanzor2, a compact eukaryotic genome-editing protein with huge potential.

Credit

St. Jude Children's Research Hospital

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.